Detecting plasma SHOX2, HOXA9, SEPTIN9, and RASSF1A methylation and circulating cancer cells for cholangiocarcinoma clinical diagnosis and monitoring

doi:10.4251/wjgo.v17.i4.104253

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (142)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-8)

Tables (1-3)

Sum=119

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=16

Apr 15, 2025 (publication date) through Mar 28, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Apr 15, 2025; 17(4): 104253
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.104253

Full Size Figure Download Figure

Figure 7 Nomograms to predict the diagnosis of patients with cholangiocarcinoma. The nomograms comprise the levels of carbohydrate antigen 19-9, methylation, and other significant indicators. The points total is located on the total point axis, and a vertical line is traced down to the diagnostic axes to predict the likelihood of a risk. CTC: Circulating tumor cell; CA199: Carbohydrate antigen 19-9.

Citation: Yu J, Liu QC, Lu SY, Wang S, Zhang H. Detecting plasma SHOX2, HOXA9, SEPTIN9, and RASSF1A methylation and circulating cancer cells for cholangiocarcinoma clinical diagnosis and monitoring. World J Gastrointest Oncol 2025; 17(4): 104253
URL: https://www.wjgnet.com/1948-5204/full/v17/i4/104253.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.104253